Katodritou, E., Kyrtsonis, M., Delimpasi, S., Kyriakou, D., Symeonidis, A., Spanoudakis, E., . . . Terpos, E. (2018). Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: Treatment at biochemical relapse is a significant prognostic factor for progression-free survival. Ann Hematol.
استشهاد بنمط شيكاغوKatodritou, Eirini, et al. "Real-world Data On Len/Dex Combination At Second-line Therapy of Multiple Myeloma: Treatment At Biochemical Relapse Is a Significant Prognostic Factor for Progression-free Survival." Ann Hematol 2018.
MLA استشهادKatodritou, Eirini, et al. "Real-world Data On Len/Dex Combination At Second-line Therapy of Multiple Myeloma: Treatment At Biochemical Relapse Is a Significant Prognostic Factor for Progression-free Survival." Ann Hematol 2018.